ClinicalTrials.gg
Status unknownNCT05155735Updated Jan 23, 2023

Functional Outcomes of Single Digit Replantation Versus Revision Amputation

An observational study in Amputation; Traumatic, Hand, sponsored by Centre hospitalier de l'Université de Montréal (CHUM). Status unknown at 1 site in Canada. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2023-01-23.

Sponsored by Centre hospitalier de l'Université de Montréal (CHUM) · Observational

The sponsor has not verified this record recently (last verified Jan 2023), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
30
Ages
18 Years to 99 Years
Sex
All
01

Study summary

The purpose of this study is to compare functional outcomes in single digit replantation subjects compared with revision amputation. Functional outcomes will be assessed by DASH (disabilities of the arm, shoulder and hand) score and with Purdue Pegboard Test by the subject's respective hand therapist at their last visit. Results will contribute to generating a preoperative decision algorithm for single digit amputation injuries.

Read the detailed description

Research design: Prospective observational cohort study

Study population, enrollment, and duration of participation:

Collaborating institutions Revision amputation cohort: CHUM, Santa Cabrini Hospital and Maisonneuve Rosemont Hospital Replantation cohort: CEVARMU/CHUM

Inclusion Criteria: All replantation and revision amputation of single digits who are treated at the collaborating hospital centres Exclusion Criteria: Thumb amputation, Multiple digit amputation, Failure to follow-up with an occupational therapist

Enrollment:

Database encompassing regional plastic surgery interventions will be reviewed to target patients who underwent single digit replantation and revision amputation in the last year, up until the first patient that is not scheduled to come back for evaluation with his hand therapist (as not to introduce a selection bias). Going forward we will run prospectively until we have sufficient data to yield significant results, as the rarity of single digit replantation will be the limiting factor. On call plastic surgery residents at our institution will also be advised to contact the research personnel when they encounter possible candidates at the participating hospitals. The research personnel will in no instance intervene nor influence the decision-making process leading to either revision amputation or replantation of the single digit. Post-operatively, the research personnel will review the patient files to select participants meeting the selection criteria.

Participants will be classified to the following groups according to the intervention performed:

  • Replantation group
  • Revision amputation group
  • Crossover group (initially replanted, then underwent revision amputation) Subgroups
  • Injured digit (index, middle, ring, little)
  • Injury level: Tamai classification

    • Zone 1 (distal to FDP insertion)
    • Zone 2 (distal to interphalangeal joint until FDP insertion)
    • Zone 3 (middle phalanx distal to FDS insertion)
    • Zone 4 (proximal phalanx until middle phalanx FDS insertion) o Zone 5 (metacarpophalangeal joint and proximal)
  • Mechanism of injury o Guillotine

    • Minor crush
    • Major crush o Avulsion

The following data will be retrieved from the patients filles:

Demographic variables/Patient characteristics

  • Age
  • Gender
  • Smoking status: cigarette and cannabis
  • Patient comorbidity:

    • Diabetes mellitus
    • Hypertension
  • Hand dominance
  • Patient preference: cultural beliefs Variables possibly influencing outcome
  • Ischemia time
  • Workers' compensation
  • Revision surgery
  • Acute post-op complications o Infection

    • Bleeding
    • Vascular thrombosis o Other
  • Chronic complications o Tendon rupture

    • Tendon adhesions
    • Bony malunion
    • Bony non-union
    • Painful neuroma formation o CRPS
    • Other

Evaluation phase and follow-up Each patient's respective hand therapist will then be contacted to be introduced to the research protocol. Instructions regarding patient consent and evaluation tools will be explained. Hand therapists who have the necessary materials and tools to administer the tests and who are willing to participate in the study will receive a copy of the research protocol, detailed instructions regarding their participation and the consent form.

End-of-hand therapy is defined as the last or second-to-last follow-up appointment with the collaborating hand therapist. At this moment, the hand therapist will introduce the patient to the research protocol and will obtain their informed written consent. The DASH score (appendix 1) will then be administered by the occupational therapist in a standardized manner to all participants. Lastly, a quantitative hand function test will be conducted using the Purdue Pegboard according to the standardized procedure described in the user manual by Lafayette Instrument Company, Inc. Both the injured and the non-injured hand will be tested.

A secured online excel sheet will be shared amongst all the collaborating occupational therapists to record the test results.

Statistical Methods:

In order to detect a significant difference in average functional outcome between the two study groups, we will conduct a two-sided t-test using the SPSS software (IBM SPSS, V26, NY). By choosing our cut-off to be 0.05 and a beta of 0.1, we gained 90% power (1 - beta), accordingly we will deem a p-value of ≤ 0.05 as statistically significant. Continuous data will be expressed as mean and standard deviation or median and range, and assessed with t test. Categorical (nominal) data will be summarized as the frequency (%) and we will utilize Pearson Chi-Square and Fisher's exact tests for analysis. We then will analyze the outcomes by logistic regression model comprising two study groups, sex, patient's comorbidities and habit of smoking, and the mechanism of injury. Multiple linear regression analysis will be performed to measure and control confounding variables.

Results obtained from the study will then be used to generate a preoperative decision algorithm for single digit replantation vs. revision amputation. This could help guide clinicians from peripheral centres with questions about medico-legal issues.

Safety Management:

Since the study procedures are not greater than minimal risk, serious adverse events (SAE) are not expected. If any unanticipated problems related to the research involving risks to subjects or others happen during the course of this study (including SAEs) these will be reported to the IRB in accordance with the procedure described in the Mode opératoire normalisé-10: Gestion des évènements indésirables. Adverse events (AEs) that are not serious but that are notable and could involve risks to subjects will be summarized in narrative or other format and submitted to the CÉR at the time of continuing review.

02

Conditions studied

  • Amputation; Traumatic, Hand

Browse trials for

Keywords

  • Replantation
  • Single digit
  • function
  • DASH
03

In context

Amputation, Traumatic

112 studies on the registry are indexed under Amputation, Traumatic; 24 are open to participants now.

This study's planned enrollment of 30 is below the median of 37 across 34 observational studies indexed under Amputation, Traumatic.

Browse Amputation, Traumatic studies →

Lead sponsor

Centre hospitalier de l'Université de Montréal (CHUM) is the lead sponsor of 376 studies on the registry; 110 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All subjects who have suffered a single digit amputation who are treated at the collaborating hospital centres

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Replantation of single digits treated at collaborating hospital centres
  • Revision amputation of single digits treated at collaborating hospital centres

Exclusion criteria

Exclusion Criteria:

  • Thumb amputation
  • Multiple digit amputation
  • Failure to follow-up with hand therapist
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
30 participants (estimated)
Patient registry
No

Groups and cohorts

  • Replantation

    This group will include subjects who suffered a single digit non-thumb amputation, and whose finger was replanted.

    Procedure: Replantation

  • Revision Amputation

    This group will include subjects who suffered a single digit non-thumb amputation, and whose finger was not replanted.

    Procedure: Primary wound closure

Interventions

  • ProcedureReplantation

    Surgical reattachment of a severed body part

  • ProcedurePrimary wound closure

    Primary wound closure with removal of exposed bone

06

What researchers measure

Primary outcomes

  1. Functional outcome by DASH score

    Measured by DASH score (higher scores indicate a greater level of disability, score range from 0 to 100)

    Time frame: Immediately following patient discharge from hand therapy

  2. Functional outcome by Purdue Pegboard Test

    Measured by Purdue Pegboard Test (higher scores indicate a greater level of dexterity and functionality and are typically compared with normative data stratified on the basis of age, score range depends on how the test is administered)

    Time frame: Immediately following patient discharge from hand therapy

  3. Functional outcome by Michigan Hand Questionnaire

    Measured by Michigan Hand Questionnaire (higher scores indicate a greater level of functionality, score range from 0 to 100)

    Time frame: Immediately following patient discharge from hand therapy

07

Study locations

1 of 1 sites recruiting
  • Maisonneuve-Rosemont Hospital
    Montréal-Est, Quebec H1T2M4, Canada
    Recruiting
08

References and documents

Publications

  • Stone N, Shah A, Chin B, McKinnon V, McRae M. Comparing digital replantation versus revision amputation patient reported outcomes for traumatic digital amputations of the hand: A systematic review and meta-analysis. Microsurgery. 2021 Jul;41(5):488-497. doi: 10.1002/micr.30738. Epub 2021 Apr 3. PubMed 33811398 ↗
  • Kaplan FT, Raskin KB. Indications and surgical techniques for digit replantation. Bull Hosp Jt Dis. 2001-2002;60(3-4):179-88. PubMed 12102407 ↗
  • Tejedor Navarro A, Vendrell Jorda M, Puente Alonso C. Digital replantation/revascularization: predictive factors to microsurgery success-a single-center study. Eur J Trauma Emerg Surg. 2021 Feb;47(1):225-232. doi: 10.1007/s00068-019-01226-x. Epub 2019 Sep 24. PubMed 31552437 ↗
  • Zhu H, Bao B, Zheng X. A Comparison of Functional Outcomes and Therapeutic Costs: Single-Digit Replantation versus Revision Amputation. Plast Reconstr Surg. 2018 Feb;141(2):244e-249e. doi: 10.1097/PRS.0000000000004024. PubMed 29036026 ↗
  • Shaterian A, Sayadi LR, Tiourin E, Gardner DJ, Evans GRD, Leis A. Predictors of Hand Function Following Digit Replantation: Quantitative Review and Meta-Analysis. Hand (N Y). 2021 Jan;16(1):11-17. doi: 10.1177/1558944719834658. Epub 2019 Apr 2. PubMed 30938181 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 23, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05155735
Responsible party
Sponsor
First posted
Dec 14, 2021
Start date
Jan 17, 2023
Primary completion
May 15, 2024 (estimated)
Completion
Nov 15, 2024 (estimated)
Last update
Jan 23, 2023

Study contacts

Ophelie Doucet
Contact
ophelie.doucet@umontreal.ca
5148908000
Bruno Mastropasqua, MD
principal investigator · Université de Montréal

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion